LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the appointment of Mark H.N. Corrigan, M.D., to its Board of Directors. Dr. Corrigan is Executive Vice President, Research & Development at Sepracor, Inc. He also serves on the board of NeuroMed Technologies, Inc.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.